[Effect of 1 alpha-hydroxycholecalciferol (1 alpha-OH-D3) and eel calcitonin derivative in experimental renal osteodystrophy].
D000818:Animals; D002116:Calcitonin / Q000627:therapeutic use*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy*; D004524:Eels; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D051381:Rats
D006887:Hydroxycholecalciferols; D002116:Calcitonin